Senti Biosciences Holdings, Inc.

American Society of Hematology (ASH) Annual Meeting 2025Nosha Farhadfar, Stephen Strickland, Ashish Bajel, Alireza Eghtedar, Brian Garrison, Rochelle Emery, Kanya Rajangam, Gary Schiller, Farhad Ravandi The post Promising results from an ongoing Phase I multicenter study of SENTI-202, a first-in-class, CD33 and/or FLT3 & not endomucin (EMCN), selective off-the-shelf logic gated CAR NK cell therapy in adults with Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) appeared first on Senti Bio.

American Society of Hematology (ASH) Annual Meeting 2025Muharrem Muftuoglu, Enping Hong, Nosha Farhadfar, Stephen A. Strickland, Ashish R. Bajel, Alireza Eghtedar, Gary Schiller, Mahesh Basyal, Li Li, Lawrence Naitmazi, Rochelle Emery, Timothy Lu, Brian S. Garrison, Kanya Rajangam, Farhad Ravandi, Michael Andreeff The post Correlative data from an ongoing Phase 1, multicenter study of SENTI-202, a first-in-class, CD33 and/or FLT3 & not endomucin (EMCN), selective off-the-shelf CAR NK cell therapy for Acute Myeloid Leukemia (AML) is consistent with its clinical activity and unique logic gated mechanism of action appeared first on Senti Bio.

Mr. Baum is a serial entrepreneur and investor and is the Co-Founder and Managing Partner of K5 Global. His portfolio includes category-defining companies such as SpaceX, xAI, Anduril, Canva, Databricks, Grafana, OpenAI, and others. He has also founded and successfully exited multiple ventures. Mr. Baum also started 818 Tequila and previously founded and sold multiple companies […] The post Bryan Baum appeared first on Senti Bio.

AACR Annual MeetingMuharrem Muftuoglu, Mahesh Basyal, Li Li, Jiangxing Lv, Lauren Ostermann, Han Deng, Priscilla Wong, Timothy K. Lu, Brian S. Garrison, Kanya Rajangam, Michael Andreeff The post SENTI-202 CD33 OR FLT3 NOT EMCN Logic-Gated Gene Circuit Components Selectively Target AML while Protecting Human HSC/HPCs from Off-Tumor Toxicity in a Humanized Mouse Model  appeared first on Senti Bio.

AACR Annual MeetingMuharrem Muftuoglu, Enping Hong, Stephen A. Strickland, Alireza Eghtedar, Gary Schiller, Nosha Farhadfar, Ashish R. Bajel, Farhad Ravandi, Mahesh Basyal, Li Li, Lawrence Naitmazi, Rochelle Emery,Brian S. Garrison, Timothy Lu, Kanya Rajangam, Michael Andreeff The post First-In-Human, Multicenter Study of SENTI-202, a CD33/FLT3 Selective Off-the-Shelf Logic Gated CAR NK Cell Therapy in Hematologic Malignancies including AML: Correlative Data appeared first on Senti Bio.

AACR Annual MeetingStephen A. Strickland, Alireza Eghtedar, Nosha Farhadfar, Ashish R. Bajel, Farhad Ravandi, Rochelle Emery, Brian Garrison, Muharrem Muftuoglu, Michael Andreeff, Kanya Rajangam, Gary Schiller The post First-In-Human, Multicenter Study of SENTI-202, a CD33/FLT3 Selective Off-the-Shelf Logic Gated CAR NK Cell Therapy in Hematologic Malignancies including AML: Clinical Data appeared first on Senti Bio.

Mr. Hsiung is the Founder, Chief Investment Officer, and Chief Executive Officer of Acion Partners, an investment advisor firm that has a strategic partnership with KKR and invests across industries. From 2007 through 2014, Mr. Hsiung was a Partner and the Chief Executive Officer (Asia) at York Capital. He started its Asia business as the […] The post Feng Hsiung appeared first on Senti Bio.

Mr. Siddiqui brings over 27 years of biopharmaceutical experience with a proven track record in novel modalities and exceptional leadership to Senti, where he is responsible for technical operations including process development, manufacturing and supply chain. Previously, Mr. Siddiqi was SVP Manufacturing Operations at IGM Biosciences where he oversaw end-to-end manufacturing operations, clinical supply chain, […] The post Faraz Siddiqui appeared first on Senti Bio.

Mr. Tang is the Managing Partner of Celadon Partners, a private equity firm that he founded in 2018. From 2004 to 2017, Mr. Tang worked at D.E. Shaw & Co., most recently as chief executive officer of D.E. Shaw & Co. (Asia-Pacific). He was the sole D.E. Shaw & Co. partner on the investment side […] The post Donald Tang appeared first on Senti Bio.

Ms. Schulz has served as a member of our board of directors since 2024. Ms. Schulz was one of the founding members and senior partners in Ernst & Young’s (EY) Life Sciences Practice and has held various roles at EY over 35 years. While at EY, Ms. Schulz directly contributed to the growth of EY […] The post Fran Schulz appeared first on Senti Bio.